TLSI · TriSalus Life Sciences Inc. Common Stock
View on chartInsiders & Stakes
| Frankenius Equity AB | ▼ Sell | Other | 6,989,748 Shares held | 7/31/2025 | View profile |
| MedTech Acquisition Sponsor LLC 10% Owner | ▼ Sell | Other | 6,249,999 Shares held | 6/26/2023 | View profile |
| David J. Matlin Director | ▲ Buy | Grant | 1,323,210 Shares held | 5/14/2026 | View profile |
| Mary T. Szela CEO and President | ▲ Buy | Grant | 1,077,683 Shares held | 6/30/2026 | View profile |
| HICKS KERRY R Director | ▲ Buy | Grant | 542,790 Shares held | 5/14/2026 | View profile |
| Stansky Michael P Director | ▲ Buy | Open Market | 399,698 Shares held | 5/15/2026 | View profile |
| Patience David Chief Financial Officer | ▼ Sell | Tax Withholding | 261,107 Shares held | 7/1/2026 | View profile |
| Martin George Kelly | ▼ Sell | Open Market | 247,176 Shares held | 8/28/2024 | View profile |
| Desai Arjun JJ | ▼ Sell | Open Market | 247,127 Shares held | 12/10/2024 | View profile |
| Cox Bryan F. Chief of Research | ▼ Sell | Open Market | 163,415 Shares held | 3/16/2026 | View profile |
| Mats Wahlstrom Director | ▲ Buy | Open Market | 147,555 Shares held | 5/15/2026 | View profile |
| Marshak Richard Chief Commercial Officer | ▲ Buy | Grant | 128,319 Shares held | 6/30/2026 | View profile |
| Stevens Jennifer Chief Regulatory Officer | ▼ Sell | Open Market | 124,110 Shares held | 3/16/2026 | View profile |
| Murphy Sean CHIEF FINANCIAL OFFICER | ▲ Buy | Grant | 123,989 Shares held | 5/19/2025 | View profile |
| Devlin Jodi PRESIDENT, COMMERC. OPERATIONS | ▼ Sell | Open Market | 97,364 Shares held | 3/16/2026 | View profile |
| Marshall Richard Henry Chief Medical Officer | ▲ Buy | Grant | 90,000 Shares held | 6/29/2026 | View profile |
| Valle William Director | ▲ Buy | Grant | 83,241 Shares held | 5/14/2026 | View profile |
| Gordon Gary B. Director | ▲ Buy | Open Market | 72,510 Shares held | 5/15/2026 | View profile |
| Katz Steven C CHIEF MEDICAL OFFICER | ▲ Buy | Grant | 68,587 Shares held | 2/12/2024 | View profile |
| Young James Emmett Chief Financial Officer | ▲ Buy | Grant | 49,663 Shares held | 5/19/2025 | View profile |
| Magnetar Financial LLC 10% Owner | ▼ Sell | Other | 16,668 Shares held | 6/12/2023 | View profile |
| Hyveled Liselotte | ▲ Buy | Grant | 10,040 Shares held | 1/2/2025 | View profile |
Transaction History
| Patience David | ▼ Sell | Tax Withholding | 14,650 | $65K | 7/1/2026 |
| Mary T. Szela | ▲ Buy | Grant | 3,990 | $15K | 6/30/2026 |
| Marshak Richard | ▲ Buy | Grant | 561 | $2K | 6/30/2026 |
| Marshall Richard Henry | ▲ Buy | Grant | 60,000 | $0 | 6/29/2026 |
| Marshak Richard | ▼ Sell | Open Market | 543 | $1K | 5/15/2026 |
| Mats Wahlstrom | ▲ Buy | Open Market | 60,000 | $152K | 5/15/2026 |
| Stansky Michael P | ▲ Buy | Open Market | 410,000 | $1.0M | 5/15/2026 |
| Stansky Michael P | ▲ Buy | Open Market | 200,000 | $500K | 5/15/2026 |
| Mary T. Szela | ▲ Buy | Open Market | 39,682 | $103K | 5/15/2026 |
| Patience David | ▲ Buy | Open Market | 7,100 | $17K | 5/15/2026 |
| Gordon Gary B. | ▲ Buy | Open Market | 10,000 | $25K | 5/15/2026 |
| HICKS KERRY R | ▲ Buy | Grant | 28,201 | $0 | 5/14/2026 |
| Mats Wahlstrom | ▲ Buy | Grant | 37,602 | $0 | 5/14/2026 |
| Mats Wahlstrom | ▲ Buy | Grant | 34,226 | $0 | 5/14/2026 |
| Gordon Gary B. | ▲ Buy | Grant | 28,201 | $0 | 5/14/2026 |
| Gordon Gary B. | ▲ Buy | Grant | 24,553 | $0 | 5/14/2026 |
| David J. Matlin | ▲ Buy | Grant | 28,201 | $0 | 5/14/2026 |
| David J. Matlin | ▲ Buy | Grant | 23,065 | $0 | 5/14/2026 |
| Valle William | ▲ Buy | Grant | 28,201 | $0 | 5/14/2026 |
| Valle William | ▲ Buy | Grant | 24,553 | $0 | 5/14/2026 |
| Stansky Michael P | ▲ Buy | Grant | 23,501 | $0 | 5/14/2026 |
| Stansky Michael P | ▲ Buy | Grant | 20,089 | $0 | 5/14/2026 |
| Mary T. Szela | ▼ Sell | Open Market | 15,944 | $61K | 3/17/2026 |
| Devlin Jodi | ▼ Sell | Open Market | 273 | $1K | 3/16/2026 |
| Cox Bryan F. | ▼ Sell | Open Market | 579 | $2K | 3/16/2026 |
| Marshak Richard | ▼ Sell | Open Market | 419 | $2K | 3/16/2026 |
| Stevens Jennifer | ▼ Sell | Open Market | 774 | $3K | 3/16/2026 |
| Devlin Jodi | ▼ Sell | Open Market | 1,772 | $7K | 3/12/2026 |
| Cox Bryan F. | ▼ Sell | Open Market | 1,467 | $6K | 3/12/2026 |
| Marshak Richard | ▼ Sell | Open Market | 1,589 | $6K | 3/12/2026 |
| Stevens Jennifer | ▼ Sell | Open Market | 1,552 | $6K | 3/12/2026 |
| Devlin Jodi | ▼ Sell | Open Market | 1,162 | $5K | 3/11/2026 |
| Cox Bryan F. | ▼ Sell | Open Market | 1,138 | $5K | 3/11/2026 |
| Marshak Richard | ▼ Sell | Open Market | 1,449 | $6K | 3/11/2026 |
| Stevens Jennifer | ▼ Sell | Open Market | 1,204 | $5K | 3/11/2026 |
| Mary T. Szela | ▼ Sell | Open Market | 4,358 | $18K | 3/11/2026 |
| Gordon Gary B. | ▲ Buy | Open Market | 9,756 | $40K | 2/23/2026 |
| Valle William | ▲ Buy | Open Market | 30,487 | $125K | 2/23/2026 |
| Patience David | ▲ Buy | Open Market | 3,657 | $15K | 2/23/2026 |
| Mary T. Szela | ▲ Buy | Open Market | 30,487 | $125K | 2/23/2026 |
| Stansky Michael P | ▲ Buy | Open Market | 243,900 | $1000K | 2/23/2026 |
| Stansky Michael P | ▲ Buy | Open Market | 117,198 | $481K | 2/23/2026 |
| Cox Bryan F. | ▲ Buy | Grant | 40,000 | $0 | 11/24/2025 |
| Devlin Jodi | ▲ Buy | Grant | 50,000 | $0 | 11/24/2025 |
| Mary T. Szela | ▲ Buy | Grant | 125,000 | $0 | 11/24/2025 |
| Mary T. Szela | ▲ Buy | Grant | 300,000 | $0 | 11/24/2025 |
| Stevens Jennifer | ▲ Buy | Grant | 50,000 | $0 | 11/24/2025 |
| Marshak Richard | ▲ Buy | Grant | 60,000 | $0 | 11/24/2025 |
| Patience David | ▲ Buy | Grant | 65,000 | $0 | 11/24/2025 |
| Patience David | ▲ Buy | Grant | 200,000 | $0 | 8/14/2025 |
| David J. Matlin | ▼ Sell | Other | 330,000 | $0 | 7/31/2025 |
| Frankenius Equity AB | ▼ Sell | Other | 759,000 | $0 | 7/31/2025 |
| Marshak Richard | ▼ Sell | Open Market | 6,597 | $34K | 5/19/2025 |
| Murphy Sean | ▲ Buy | Grant | 44,884 | $232K | 5/19/2025 |
| Stevens Jennifer | ▲ Buy | Grant | 28,455 | $147K | 5/19/2025 |
| Stevens Jennifer | ▼ Sell | Open Market | 8,704 | $45K | 5/19/2025 |
| Devlin Jodi | ▼ Sell | Open Market | 4,764 | $25K | 5/19/2025 |
| Marshak Richard | ▲ Buy | Grant | 21,428 | $111K | 5/19/2025 |
| Devlin Jodi | ▲ Buy | Grant | 24,131 | $125K | 5/19/2025 |
| Young James Emmett | ▲ Buy | Grant | 13,175 | $68K | 5/19/2025 |
| Cox Bryan F. | ▲ Buy | Grant | 15,722 | $81K | 5/19/2025 |
| Cox Bryan F. | ▼ Sell | Open Market | 4,764 | $25K | 5/19/2025 |
| Murphy Sean | ▲ Buy | Grant | 15,817 | $0 | 2/18/2025 |
| Young James Emmett | ▲ Buy | Grant | 14,762 | $0 | 2/18/2025 |
| Stevens Jennifer | ▲ Buy | Grant | 14,481 | $0 | 2/18/2025 |
| Mary T. Szela | ▲ Buy | Grant | 21,089 | $0 | 2/18/2025 |
| Devlin Jodi | ▲ Buy | Grant | 5,272 | $0 | 2/18/2025 |
| Marshak Richard | ▲ Buy | Grant | 7,644 | $0 | 2/18/2025 |
| Cox Bryan F. | ▲ Buy | Grant | 11,450 | $0 | 2/18/2025 |
| Young James Emmett | ▲ Buy | Open Market | 6,000 | $34K | 2/5/2025 |
| Mary T. Szela | ▲ Buy | Open Market | 5,010 | $26K | 1/30/2025 |
| Mary T. Szela | ▲ Buy | Open Market | 5,030 | $25K | 1/29/2025 |
| Mary T. Szela | ▲ Buy | Open Market | 4,716 | $24K | 1/28/2025 |
| Murphy Sean | ▲ Buy | Open Market | 15,000 | $78K | 1/28/2025 |
| Mary T. Szela | ▲ Buy | Grant | 40,000 | $0 | 1/27/2025 |
| Mary T. Szela | ▲ Buy | Open Market | 4,826 | $26K | 1/27/2025 |
| Murphy Sean | ▲ Buy | Open Market | 15,000 | $80K | 1/27/2025 |
| Devlin Jodi | ▲ Buy | Grant | 10,625 | $0 | 1/27/2025 |
| Marshak Richard | ▲ Buy | Grant | 12,500 | $0 | 1/27/2025 |
| Stevens Jennifer | ▲ Buy | Grant | 10,625 | $0 | 1/27/2025 |
| Young James Emmett | ▲ Buy | Open Market | 24,000 | $130K | 1/27/2025 |
| Young James Emmett | ▲ Buy | Grant | 12,500 | $0 | 1/27/2025 |
| Murphy Sean | ▲ Buy | Grant | 12,500 | $0 | 1/27/2025 |
| Cox Bryan F. | ▲ Buy | Grant | 10,625 | $0 | 1/27/2025 |
| David J. Matlin | ▲ Buy | Grant | 10,040 | $0 | 1/2/2025 |
| Hyveled Liselotte | ▲ Buy | Grant | 10,040 | $0 | 1/2/2025 |
| Mats Wahlstrom | ▲ Buy | Grant | 25,188 | $100K | 12/17/2024 |
| Frankenius Equity AB | ▲ Buy | Open Market | 62,972 | $250K | 12/17/2024 |
| Desai Arjun JJ | ▼ Sell | Open Market | 30,000 | $111K | 12/10/2024 |
| Mats Wahlstrom | ▲ Buy | Open Market | 5,000 | $23K | 11/22/2024 |
| Mats Wahlstrom | ▲ Buy | Open Market | 8,687 | $39K | 11/21/2024 |
| Mats Wahlstrom | ▲ Buy | Open Market | 2,040 | $8K | 11/20/2024 |
| Marshak Richard | ▲ Buy | Grant | 6,875 | $0 | 11/14/2024 |
| Cox Bryan F. | ▼ Sell | Open Market | 314 | $1K | 10/5/2024 |
| Mary T. Szela | ▲ Buy | Open Market | 1,295 | $6K | 9/13/2024 |
| Mary T. Szela | ▲ Buy | Open Market | 6,000 | $30K | 9/13/2024 |
| Mary T. Szela | ▲ Buy | Open Market | 7,520 | $39K | 9/12/2024 |
| Mary T. Szela | ▲ Buy | Open Market | 5,000 | $25K | 9/10/2024 |
| Martin George Kelly | ▼ Sell | Open Market | 9 | $50 | 8/28/2024 |
| Desai Arjun JJ | ▲ Buy | Grant | 74,000 | — | 7/1/2024 |
| Mary T. Szela | ▲ Buy | Grant | 84,899 | $0 | 2/13/2024 |
| Mary T. Szela | ▲ Buy | Grant | 125,000 | $0 | 2/13/2024 |
| Marshak Richard | ▲ Buy | Grant | 14,752 | $0 | 2/12/2024 |
| Murphy Sean | ▲ Buy | Grant | 34,144 | $0 | 2/12/2024 |
| Cox Bryan F. | ▲ Buy | Grant | 14,752 | $0 | 2/12/2024 |
| Stevens Jennifer | ▲ Buy | Grant | 14,752 | $0 | 2/12/2024 |
| Katz Steven C | ▲ Buy | Grant | 34,144 | $0 | 2/12/2024 |
| Devlin Jodi | ▲ Buy | Grant | 17,500 | $0 | 2/12/2024 |
| David J. Matlin | ▼ Sell | Other | 931,904 | — | 8/10/2023 |
| MedTech Acquisition Sponsor LLC | ▼ Sell | Other | 6,249,999 | — | 6/26/2023 |
| Magnetar Financial LLC | ▼ Sell | Other | 67,992 | $713K | 6/12/2023 |
| Magnetar Financial LLC | ▼ Sell | Other | 107,904 | $1.1M | 6/12/2023 |
| Magnetar Financial LLC | ▼ Sell | Other | 21,887 | $230K | 6/12/2023 |
| Magnetar Financial LLC | ▼ Sell | Other | 85,137 | $893K | 6/12/2023 |
| Magnetar Financial LLC | ▼ Sell | Other | 38,079 | $399K | 6/12/2023 |
| Magnetar Financial LLC | ▼ Sell | Other | 5,112 | $54K | 6/12/2023 |
| Magnetar Financial LLC | ▼ Sell | Other | 27,891 | $292K | 6/12/2023 |
| Magnetar Financial LLC | ▼ Sell | Other | 16,032 | $168K | 6/12/2023 |
| Magnetar Financial LLC | ▼ Sell | Other | 42,567 | $446K | 6/12/2023 |
| Magnetar Financial LLC | ▼ Sell | Other | 33,227 | $348K | 6/12/2023 |
AI Market Commentary
AI-generatedAll commentary →Synthesized from recent news and fundamentals/technical data -- not human analyst commentary or trader sentiment.
September 27, 2026
TriSalus Stock Rises After FDA Clears TriNav Advance
TriSalus Life Sciences shares climbed 15.6% following FDA clearance for its TriNav Advance product. This regulatory approval marks a significant milestone for the company's pipeline. The stock is currently testing key support levels after the recent price movement.
TriSalus Stock Rises After FDA Clears TriNav Advance. TriSalus Life Sciences shares climbed 15.6% following FDA clearance for its TriNav Advance product. This regulatory approval marks a significant milestone for the company's pipeline. The stock is currently testing key support levels after the recent price movement.